Author Question: More people in the United States are ending up with a chronic and disabling condition, ranging from ... (Read 39 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
More people in the United States are ending up with a chronic and disabling condition, ranging from arthritis (inflammation of the joints) to Alzheimer's disease (loss of brain function) mainly because
 
  a. these conditions affect the poor.
  b. antibiotics are losing their effectiveness.
  c. these conditions are contagious.
  d. people are living longer.

Question 2

The U.S. Census Bureau estimates that what percentage of the elderly have some disability?
 
  a. 6 percent
  b. 16 percent
  c. 36 percent
  d. 56 percent



jgranad15

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

(Answer: d)

Answer to Question 2

(Answer: c)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library